KCNA3 and Prolonged QT interval: Therefore, several studies have promoted the need for novel pharmacological drugs that increase or even restore the function of mutated potassium channels critical for cardiomyocyte repolarization; as these drugs could potentially be used to treat Long QT syndrome in carriers with loss-of-function potassium channel mutations (Anderson et al., 2014; Perry et al., 2016).